Amgen, Inc. (AMGN)
336.85
+0.37
(+0.11%)
USD |
NASDAQ |
May 29, 16:00
336.80
-0.05
(-0.01%)
After-Hours: 16:41
Amgen Market Cap : 181.80B for May 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 28.95B |
| Gilead Sciences, Inc. | 167.04B |
| Regeneron Pharmaceuticals, Inc. | 64.39B |
| AbbVie, Inc. | 384.51B |
| Moderna, Inc. | 18.72B |
Market Cap Related Metrics
| PE Ratio | 23.43 |
| PS Ratio | 4.899 |
| PEG Ratio | 0.7494 |
| Price to Book Value | 19.78 |
| Price to Free Cash Flow | 21.26 |
| Price | 336.85 |
| Earnings Yield | 4.27% |
| PEGY Ratio | 0.6856 |
| Operating PE Ratio | 15.43 |
| Normalized PE Ratio | 21.16 |